Microglial activation parallels system degeneration in multiple system atrophy

Keisuke Ishizawa1, Takashi Komori, Shoichi Sasaki

  • 1Department of Pathology, Saitama Medical School, Saitama, Japan. ishizawa@saitama-med.ac.jp

Insights

Microglia activation and glial cytoplasmic inclusions (GCIs) are system-specific in Multiple System Atrophy (MSA). Microglial activation correlates with GCIs in affected motor systems, suggesting a role in MSA pathogenesis.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple system atrophy (MSA) is a neurodegenerative disease affecting motor pathways.
  • The specific role of microglia in MSA pathogenesis remains unclear.
  • Microglia are immune cells in the brain implicated in neuroinflammation.

Purpose of the Study:

  • To investigate the distribution and burden of activated microglia and glial cytoplasmic inclusions (GCIs) in MSA.
  • To determine the relationship between microglial activation and GCIs in different neuroanatomic systems within the MSA brain.
  • To explore the potential role of microglia in the system-specific pathology of MSA.

Main Methods:

  • Quantitative image analysis of brain sections from 13 MSA cases (8 cerebellar, 5 parkinsonian variants).
  • Immunostaining using antibodies for HLA-DR (microglia marker) and alpha-synuclein (GCI marker).
  • Correlation analysis between microglial burden and GCI burden in specific neuroanatomic structures.

Main Results:

  • Activated microglia and GCIs were prevalent in cerebellar input, extrapyramidal motor, and pyramidal motor structures.
  • These pathological markers were absent in cerebellar output structures, indicating system-specific distribution.
  • Significant correlations between microglial and GCI burdens were found in affected motor systems, but not in cerebellar output structures.

Conclusions:

  • Microglial activation and GCI distribution are system-specific in MSA.
  • Microglial activation is likely influenced by GCIs or alpha-synuclein pathology in affected neuroanatomic systems.
  • Microglia may contribute to the system-specific tissue injury and clinical phenotypes observed in MSA.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...